<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02321670</url>
  </required_header>
  <id_info>
    <org_study_id>OUS-URO-SUPS</org_study_id>
    <nct_id>NCT02321670</nct_id>
  </id_info>
  <brief_title>Scandinavian Urethroplasty Study</brief_title>
  <acronym>SUPS</acronym>
  <official_title>Scandinavian Urethroplasty Study. A Multicentre, Prospective, Randomized Study Comparing Bulbar Urethroplasty With Excision and Primary Anastomosis or With an Onlay Grafting Procedure Using Buccal Mucosa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicentre, prospective, randomized study comparing bulbar urethroplasty with excision and&#xD;
      primary anastomosis or with an onlay grafting procedure using buccal mucosa.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, randomized study to compare two common techniques of&#xD;
      urethroplasty used to treat bulbar urethral strictures. One technique is excision of the&#xD;
      stricture and end-to-end anastomosis of the urethra. The other technique is an onlay grafting&#xD;
      procedure with buccal mucosa where the corpus spongiosum is not divided. The study is&#xD;
      designed to compare complications of sexual and penile function, and is not powered to&#xD;
      compare the success rates of the two techniques. The primary endpoint will be degree of&#xD;
      erectile dysfunction and penile complications. The secondary endpoint will be restricturing&#xD;
      leading to reoperation, and other complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">February 15, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of erectile dysfunction after surgery</measure>
    <time_frame>up to one year</time_frame>
    <description>Measured by changes in IIEF-5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Penile complications</measure>
    <time_frame>up to one year</time_frame>
    <description>Measured by questionnaire made for this study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of failure within the follow up period</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of complications</measure>
    <time_frame>From operation to one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">151</enrollment>
  <condition>Urethral Stricture</condition>
  <arm_group>
    <arm_group_label>End-to-end</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Excision of the stricture and end-to-end anastomosis of the urethra.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Incision of the stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>End-to-end</intervention_name>
    <description>Excision of the stricture and end-to-end anastomosis of the urethra.</description>
    <arm_group_label>End-to-end</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Graft</intervention_name>
    <description>Incision of stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided</description>
    <arm_group_label>Graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patient with bulbar urethral stricture, length estimated by urethrography or endoscopy ≤ 2&#xD;
        cm&#xD;
&#xD;
        Patient is able and willing to sign informed consent&#xD;
&#xD;
        Patient is able and willing to complete all study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Previous open urethroplasty&#xD;
&#xD;
        Previous hypospadia surgery&#xD;
&#xD;
        Previous surgery for congenital curvature or Mb Peyronie&#xD;
&#xD;
        Previous pelvic irradiation therapy&#xD;
&#xD;
        Known grave psychiatric disorder&#xD;
&#xD;
        Haemophilia or other clotting disorders that cause bleeding diathesis&#xD;
&#xD;
        Use of medication to increase erectile function, such as PDE5-inhibitors and intracavernous&#xD;
        injections, during the study&#xD;
&#xD;
        Any condition or situation, which, in the investigator's opinion, puts the patient at&#xD;
        significant risk, could confound the study results, or may interfere significantly with the&#xD;
        patient's participation in the study&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Schultz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital, Dept of Urology</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Dept of Urology</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital, Dept of Urology</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 17, 2014</study_first_submitted>
  <study_first_submitted_qc>December 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2014</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Ole Jacob Nilsen</investigator_full_name>
    <investigator_title>Consultant, Head of section</investigator_title>
  </responsible_party>
  <keyword>operative technique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urethral Stricture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

